Product Information

PHENOBARBITAL 64.8 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0982 per EA under NDC 69367062710. Its NADAC has been published 137 times since Nov 15, 2023.

PHENOBARBITAL 64.8 MG TABLET

Phenobarbital
$0.0982per EA
DEA Schedule CIV

Strength

64.8 mg/1

NDC

69367062710

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

PHENOBARBITAL

Approval Type

Unapproved

On Market Since

9/8/2023

Price Statistics

The NADAC for PHENOBARBITAL 64.8 MG TABLET has been published 137 times since Nov 15, 2023, and over the history we have for it it has declined 61.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0982 per EA
All-time high$0.2604 (Jan 10, 2024)
All-time low$0.0982 (Jun 17, 2026)
52-week high$0.1607
52-week low$0.0982
Median price$0.1473
Average price$0.1572
Largest weekly change+98.1% (Aug 21, 2024)
Weeks tracked137
Tracking sinceNov 15, 2023

Price History

1W

0.0%

1M

-7.6%

3M

-22.2%

6M

-26.1%

1Y

-34.3%

3Y

N/A

5Y

N/A

All

-61.2%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PHENOBARBITAL 64.8 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 64.8 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.0982 per EA (NDC 69367062710), effective Jun 24, 2026.

How has the price of PHENOBARBITAL 64.8 MG TABLET changed over time?

Over the history we have for it, the NADAC for PHENOBARBITAL 64.8 MG TABLET has declined 61.2%. It has been tracked across 137 weekly CMS publications since Nov 15, 2023.

What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 64.8 MG TABLET?

Since Nov 15, 2023, the NADAC for PHENOBARBITAL 64.8 MG TABLET has ranged from a low of $0.0982 (Jun 17, 2026) to a high of $0.2604 (Jan 10, 2024), with a median of $0.1473 per EA.

Are there cheaper alternatives to PHENOBARBITAL 64.8 MG TABLET?

4 NADAC-published products share the same active ingredient, strength, and dosage form as PHENOBARBITAL 64.8 MG TABLET, but none are currently priced below it.

Who manufactures PHENOBARBITAL 64.8 MG TABLET?

PHENOBARBITAL 64.8 MG TABLET (NDC 69367062710) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.